Search

Home > The Evidence Based Rheumatology Podcast > E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
Podcast: The Evidence Based Rheumatology Podcast
Episode:

E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
Category: Health
Duration: 00:10:04
Publish Date: 2019-08-15 21:03:51
Description:

Finally got around to tackling the JAKi this week.  I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) against adalimumab and placebo.  I briefly discuss other JAKs and my thoughts on the future of this area. Get the paper and others at ebrheum.com and follow me @ebrheum! 
Total Play: 0